- Home
- Pathology Industry
- Cell Transplantation Market and Forecasts, June 2013
Industries
- Pathology (155)
- Fruit and Vegetable (80)
- Agriculture (68)
- Biological Therapy (60)
- Agrochemical (51)
-
- Biotechnology (42)
- Drug and Medication (42)
- Blood Supply, Tissue Banking and Transplantation (38)
- Fertilizer (33)
- Energy & Environment (25)
- Water Distribution and Treatment (20)
- Diagnostics (18)
- Genomics (18)
- Horticulture (17)
- In Vitro Diagnostic (17)
- Medical Facility (17)
- Fish and Seafood (16)
- Metal and Mineral (16)
- Biopharmaceutical (12)
- Genetically Modified Organism, Gmo (12)
Top countries
Publication dates
All regions
-
- Austria (4)
- Belgium (4)
- Bulgaria (1)
- Croatia (1)
- Denmark (2)
- Finland (2)
- France (4)
- Germany (16)
- Greece (5)
- Ireland (7)
- Italy (15)
- Lithuania (1)
- Luxembourg (1)
- Macedonia (1)
- Moldova, Republic Of (1)
- Netherlands (12)
- Norway (1)
- Poland (3)
- Portugal (1)
- Romania (4)
- Russian Federation (9)
- Serbia and Montenegro (2)
- Spain (6)
- Sweden (3)
- Switzerland (4)
- United Kingdom (27)
-
- Australia (34)
- Austria (4)
- Belgium (4)
- Canada (45)
- Denmark (2)
- Finland (2)
- France (4)
- Germany (16)
- Greece (5)
- Ireland (7)
- Israel (5)
- Italy (15)
- Japan (24)
- Luxembourg (1)
- Mexico (1)
- Netherlands (12)
- New Zealand (2)
- Norway (1)
- Poland (3)
- Portugal (1)
- South Korea (6)
- Spain (6)
- Sweden (3)
- Switzerland (4)
- Turkey (5)
- United Kingdom (27)
- United States (320)
data types
- All
- Company Data (1 139)
- Industry Data
- Country Data (321)
Cell Transplantation Market and Forecasts, June 2013
You might be interested in: blood supply, stem cell, cell therapy, more »
industry reports
country reports
Stem Cell Transplant Market (stem cell transplant, bone marrow transplant) in Pakistan
- Industry report
- October 2012
- 48 pages
... And stem cell transplantation hepatitis c and bmt No evidence that bmt has any influence on the course of hcv infection or vice versa. Hepatitis c and iron overload may accelerate progression of liver ...
- Industries: Blood Supply, Tissue Banking and Transplantation
- Countries: Pakistan
World Blood Supply Industry Brief (blood supply, stem cell transplant)
- Industry report
- April 2013
- 9 pages
... In industry growth, over only an eight year period. Furthermore, stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases ...
- Industries: Blood Supply, Tissue Banking and Transplantation
- Countries: World
Cord Blood Sector Analysis in Canada
- Industry report
- September 2012
- 54 pages
... Bank All cord blood units supplied by canadian blood services for unrelated transplant are imported from international sources. The cost of importing cord blood units continues to increase ...
- Industries: Blood Supply, Tissue Banking and Transplantation
- Countries: Canada
Biological Therapy Sector Overview
- Industry report
- March 2013
- 24 pages
... Less media, and a shorter culture period to reach the target dose mechanistic studies amit bar-or (montreal ni) assessments immune cell phenotyping by flow cytometry myelin ...
- Industries: Biological Therapy
Biological Therapy Market in The United States
- Industry report
- December 2011
- 11 pages
... Potential of dli. The immune potential of tkh11001 cells was also proven as the ability to reconstitute antiviral immunity, suggesting that this technology could find specific application in transplantation ...
- Industries: Biological Therapy
- Countries: United States
Blood Cell Market Brief
- Industry report
- August 2012
- 3 pages
- by Governmental Agency
... And morbidities independent of the primary disease. For patients with low erythropoietin levels relative to the degree of anaemia, erythropoietin may increase haemoglobin sufficiently; otherwise, red blood cell ...
- Industries: Blood Supply, Tissue Banking and Transplantation
The European Cell Therapy Market : Innovation and Technology Trends
- Industry report
- May 2011
- 16 pages
... With ucl abbott laboratories > currently evaluating the market merck & co. > Interest limited to stem cells as screening tool bayer > very hesitantly evaluating the market eli lilly > ...
- Industries: Biological Therapy
- Countries: Europe
U.S. Transplantation Industry (transplantation, liver transplant)
- Industry report
- February 2013
- 22 pages
... When re- transplant occurs Time Was re-transplant necessary because of the graft or something else Combined individual covariate effects that had the most clinical impact were tested in both ...
- Industries: Blood Supply, Tissue Banking and Transplantation
- Countries: United States
U.S. Transplantation Sector Analysis (transplantation, blood supply)
- Industry report
- May 2012
- 56 pages
... Kidney, liver/heart, kidney/heart, liver/intestine, multivisceral, etc.) Belatacept as cyclosporine-free immunosuppression Islet cell transplant performing one of the first islet cell transplant surgeries ...
- Industries: Blood Supply, Tissue Banking and Transplantation
- Countries: United States
U.S. Pharmaceutical Industry Analysis
- Industry report
- March 2012
- 60 pages
... transplant are: The inaccuracy of fasting blood glucose levels as compared with postprandial measurements The inaccuracy in hemoglobin a1c (hba1c) values The importance of the oral glucose tolerance ...
- Industries: Pathology
- Countries: United States
Reportlinker.com © Copyright 2013. All rights reserved.
